securities class action

Securities class action filed against Endeavor Group Holdings for allegedly making false statements about executive compensation and share valuations. Investors must act by March 18, 2026.

Kyndryl stock plummets 55% after disclosing internal control weaknesses, executive departures, and SEC investigation, triggering securities lawsuit for alleged material misrepresentations.

Varonis Systems faces securities class action lawsuit alleging false revenue projections during SaaS transition. Lead plaintiff deadline set for March 9, 2026.

Mereo BioPharma faces securities litigation alleging it misled investors about Phase 3 clinical trial results for setrusumab, failing to disclose the trials missed primary endpoints.

Securities lawsuit filed against Ardent Health for alleged accounting misrepresentations. Lead plaintiff deadline set for March 9, 2026.

uniQure faces securities lawsuit over failing to disclose that FDA rejected its gene therapy candidate AMT-130, causing stock to plunge 49%. Lead plaintiff deadline set for April 13, 2026.

Ardent Health faces securities lawsuit over undisclosed financial declines. Lead plaintiff applications due March 9, 2026 for investors with losses exceeding $100,000.

Rosen Law Firm sues Richtech Robotics for allegedly making false claims about a Microsoft partnership. The lawsuit targets investors who bought shares January 27-29, 2026.

Rosen Law Firm sues BlackRock TCP Capital Corp. for alleged financial misstatements and improper valuations. Investors must act by April 6, 2026 deadline.

BellRing Brands faces securities lawsuit for allegedly misrepresenting organic growth, claiming revenue gains were actually from customer inventory stockpiling rather than genuine demand.

Ramaco Resources faces securities litigation over alleged misrepresentations regarding Brook Mine operations. Investors who purchased stock during July-October 2025 should consult legal counsel about joining the class action.

Ultragenyx faces securities lawsuit alleging false claims about drug setrusumab for bone disease. Investors have until April 6, 2026 deadline to join class action.

Rosen Law Firm investigates Nidec for accounting fraud allegations in China operations. Stock fell 22.7% after company disclosed accounting irregularities to investors.

REGENXBIO faces securities lawsuit over alleged false statements about gene therapy safety. Investors have until April 14 deadline to join class action after FDA clinical hold.

Robbins LLP files class action suit against Agilon Health for allegedly issuing unachievable 2025 guidance and overstating strategic initiatives, following 50% stock decline.

Klarna investors have until February 20, 2026, to join a securities class action alleging the company's IPO failed to disclose adequate loss reserves and lending risks.

Varonis Systems class action suit has March 9, 2026 deadline for investors seeking lead plaintiff status over alleged false statements.

Rosen Law Firm sues Inovio Pharmaceuticals for allegedly making false statements about manufacturing capabilities and regulatory timelines, causing investor losses through inflated stock prices.

Endeavor Group Holdings faces securities lawsuit over alleged false merger disclosures regarding share valuation, executive pay, and conflicts of interest. Lead plaintiff deadline: March 18, 2026.

BellRing Brands faces securities lawsuit alleging it misrepresented sales growth, attributing gains to inventory buildup rather than organic demand. Lead plaintiff deadline: March 23, 2026.